Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.
Small caps will be taking a short break after today, returning on Monday July 6.
Same-store sales fell 14.3 per cent, compared to a drop of 0.9 per cent a year ago.
Its net loss was US$2.5-million compared to net income of US$103,000 a year ago. Adjusted EBITDA was US$395,000 compared to US$1.2-million a year ago.
Knight Therapeutics Inc. (GUD-T) reported first-quarter revenues were $45.8-million, an increase from $3-million a year ago. Analysts were expecting revenue of $55.6-million, according to S&P Capital IQ.
Its net loss for the period was $9.5-million or a penny per share compared to net income of $5.2-million or 4 cents a year ago. Analysts were expecting a loss of 4 cents.
Adjusted earnings were $6.4-million versus $4.6-million a year ago.
Its net loss for the period ended March 31 was $16.9-million or $1.36 per share compared to a profit of $11.1-million or 51 cents a year ago.
"The COVID-19 pandemic began near the end of the period partially impacting the quarter; however, the full effects of the impacts from the COVID-19 pandemic will not be realized until the second quarter of 2020 and beyond," the company stated.
Its net loss for the quarter ended May 31 was $752.3-million or $3.61 per share basic, as compared to net income of $66.4-million or 31 cents per share last year. Adjusted EPS came in at a profit of 9 cents versus 31 cents a year ago.
Analysts were expecting adjusted EPS of 15 cents.
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.